Reduced PON1 activity has been described in a wide range of inflammatory and oxidative-stress–related conditions, including atherosclerotic cardiovascular disease, diabetes mellitus, chronic obstructive pulmonary disease, rheumatoid arthritis, and other autoimmune disorders. Here, PON1 is linked to chronic obstructive pulmonary disease.